$1.16
0.010.87%
At close: -
$1.17
0.011.29%
After Hours: Jan 23, 5:04 PM EDT
Comments
Loading...
Achilles Therapeutics (NASDAQ:ACHL) Stock, Earnings Estimates, EPS, And Revenue
Achilles Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 3
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Achilles Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Achilles Therapeutics (ACHL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.48 | $-0.41 | -17.1 % |
| Q2 | 2024-08-14 | $-0.41 | $-0.41 | 0.00 % |
| Q1 | 2024-05-08 | $-0.30 | $-0.56 | 46.4 % |
| Q4 | 2024-04-04 | $-0.46 | $-0.14 | -228.6 % |
Achilles Therapeutics (ACHL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Achilles Therapeutics (NASDAQ:ACHL) reporting earnings?
Achilles Therapeutics (ACHL) is scheduled to report earnings on April 3, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Achilles Therapeutics (NASDAQ:ACHL)?
The Actual EPS was $-0.48, which missed the estimate of $-0.41.
What were Achilles Therapeutics’s (NASDAQ:ACHL) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.